Cargando…

Soluble urokinase plasminogen activation receptor - An emerging new biomarker of cardiovascular disease and critical illness

Soluble urokinase plasminogen activation receptor (suPAR) is an emerging new biomarker, which has been shown to not only correlate with traditional biomarkers but also outperform CRP at prognosticating CVD. More clinical trials on suPAR is in the future research agenda.

Detalles Bibliográficos
Autores principales: Cyrille, Nicole B., Villablanca, Pedro A., Ramakrishna, Harish
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4900352/
https://www.ncbi.nlm.nih.gov/pubmed/27052059
http://dx.doi.org/10.4103/0971-9784.179588
_version_ 1782436617525395456
author Cyrille, Nicole B.
Villablanca, Pedro A.
Ramakrishna, Harish
author_facet Cyrille, Nicole B.
Villablanca, Pedro A.
Ramakrishna, Harish
author_sort Cyrille, Nicole B.
collection PubMed
description Soluble urokinase plasminogen activation receptor (suPAR) is an emerging new biomarker, which has been shown to not only correlate with traditional biomarkers but also outperform CRP at prognosticating CVD. More clinical trials on suPAR is in the future research agenda.
format Online
Article
Text
id pubmed-4900352
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Medknow Publications & Media Pvt Ltd
record_format MEDLINE/PubMed
spelling pubmed-49003522016-06-16 Soluble urokinase plasminogen activation receptor - An emerging new biomarker of cardiovascular disease and critical illness Cyrille, Nicole B. Villablanca, Pedro A. Ramakrishna, Harish Ann Card Anaesth Expert Brief Communication Soluble urokinase plasminogen activation receptor (suPAR) is an emerging new biomarker, which has been shown to not only correlate with traditional biomarkers but also outperform CRP at prognosticating CVD. More clinical trials on suPAR is in the future research agenda. Medknow Publications & Media Pvt Ltd 2016 /pmc/articles/PMC4900352/ /pubmed/27052059 http://dx.doi.org/10.4103/0971-9784.179588 Text en Copyright: © 2016 Annals of Cardiac Anaesthesia http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms.
spellingShingle Expert Brief Communication
Cyrille, Nicole B.
Villablanca, Pedro A.
Ramakrishna, Harish
Soluble urokinase plasminogen activation receptor - An emerging new biomarker of cardiovascular disease and critical illness
title Soluble urokinase plasminogen activation receptor - An emerging new biomarker of cardiovascular disease and critical illness
title_full Soluble urokinase plasminogen activation receptor - An emerging new biomarker of cardiovascular disease and critical illness
title_fullStr Soluble urokinase plasminogen activation receptor - An emerging new biomarker of cardiovascular disease and critical illness
title_full_unstemmed Soluble urokinase plasminogen activation receptor - An emerging new biomarker of cardiovascular disease and critical illness
title_short Soluble urokinase plasminogen activation receptor - An emerging new biomarker of cardiovascular disease and critical illness
title_sort soluble urokinase plasminogen activation receptor - an emerging new biomarker of cardiovascular disease and critical illness
topic Expert Brief Communication
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4900352/
https://www.ncbi.nlm.nih.gov/pubmed/27052059
http://dx.doi.org/10.4103/0971-9784.179588
work_keys_str_mv AT cyrillenicoleb solubleurokinaseplasminogenactivationreceptoranemergingnewbiomarkerofcardiovasculardiseaseandcriticalillness
AT villablancapedroa solubleurokinaseplasminogenactivationreceptoranemergingnewbiomarkerofcardiovasculardiseaseandcriticalillness
AT ramakrishnaharish solubleurokinaseplasminogenactivationreceptoranemergingnewbiomarkerofcardiovasculardiseaseandcriticalillness